Cytokinetics incorporated ticker

Author: mnmy

August undefined, 2024

WebWho is Cytokinetics Headquarters 350 Oyster Point Blvd, South San Francisco, California, 94080, United States Phone Number (650) 624-3000 Website www.cytokinetics.com Revenue $65M Stock Symbol CYTK Industry Pharmaceuticals Healthcare Cytokinetics's Social Media Is this data correct? View contact profiles from Cytokinetics Popular … WebApr 29, 2004 · Cytokinetics, Inc. 350 Oyster Point Blvd South San Francisco, CA 94080 Phone: 650-624-3060 Fax: 650-624-3070 Email: ...

Ticker

WebMar 31, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. indian head real estate

Cytokinetics Muscle Biology Therapies Company

WebApr 6, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as … WebCytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company... WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … indian head rental properties

Cytokinetics - CYTK - Stock Price Today - Zacks

Cytokinetics - Overview, News & Competitors ZoomInfo.com

Web2 days ago · View Cytokinetics, Incorporated CYTK investment & stock information. Get the latest Cytokinetics, Incorporated CYTK detailed stock quotes, stock data, Real … WebNFL Washington. Jan 2003 - Aug 20063 years 8 months. Ashburn, VA. As a senior member of Washington's NFL team leadership, I used my digital experience to take the team’s … local user startup folder windows 10WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. A leader in muscle biology research with ... local users \u0026 groups windows 10

"WebSelected key stats of Cytokinetics, Incorporated (CYTK) including 10 year stock price and latest news. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more. " - Cytokinetics incorporated ticker

Cytokinetics incorporated ticker

CYTK Cytokinetics, Incorporated Q2 2024 Earnings Call

WebApr 6, 2024 · CYTK Cytokinetics, Incorporated Stock Price & Overview $35.39 -0.79 ( -2.18%) 1:21 PM 03/22/23 NASDAQ $USD Realtime Summary Ratings Financials … WebFind out the direct holders, institutional holders and mutual fund holders for Cytokinetics, Incorporated (CYTK).

Did you know?

Web2 days ago · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as … WebApr 10, 2024 · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. About the company Rewards Revenue is forecast to grow 46.65% per year Risk Analysis Negative shareholders equity

WebFeb 17, 2024 · It is currently -18.08% from its 52-week high and 51.01% from its 52-week low. How much is Cytokinetics stock worth today? ( NASDAQ: CYTK) Cytokinetics currently has 94,631,001 outstanding shares. With Cytokinetics stock trading at $45.71 per share, the total value of Cytokinetics stock (market capitalization) is $4.33B. WebFeb 28, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential...

WebAnalysis of Cytokinetics Incorporated's forth quarter 2024 to forth quarter 2024 EBITDA Margin, ranking within Major Pharmaceutical Preparations industry and Healthcare Sector, EBITDA and Revenue quarterly change - CSIMarket

WebDec 10, 2024 · Cytokinetics, Incorporated (NASDAQ: CYTK) has seen an increase in hedge fund interest recently. Our calculations also showed that CYTK isn't among the 30 most popular stocks among hedge funds...

WebCytokinetics, Incorporated CYTK: Raising target price to $38.00 CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $38.000000; an Industry Subrating of … Find the latest Cytokinetics, Incorporated (CYTK) stock discussion in Yahoo … See the company profile for Cytokinetics, Incorporated (CYTK) including business … View the basic CYTK option chain and compare options of Cytokinetics, … SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- … Discover historical prices for CYTK stock on Yahoo Finance. View daily, weekly or … At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio … Find out all the key statistics for Cytokinetics, Incorporated (CYTK), … Get the detailed quarterly/annual income statement for Cytokinetics, Incorporated … Find out the direct holders, institutional holders and mutual fund holders for … See Cytokinetics, Incorporated (CYTK) Environment, Social and Governance … indian head research stationWebCytokinetics, Incorporated is a company in the U.S. stock market and it is a holding in 79 U.S.-traded ETFs. CYTK has around 18.7M shares in the U.S. ETF market. local vacation package march 26th thru 28thWebMar 16, 2024 · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle … local utility provider